Biography of Daniel Spiegelman
Last update: January 31, 2024Career
Daniel was Executive Vice President, Chief Financial Officer at BioMarin, and Chief Financial Officer at CV Therapeutics.
Daniel Spiegelman is currently- Director at Maze Therapeutics - View - Maze Therapeutics org chart
- Director at Myriad Genetics - View - Myriad Genetics org chart
- Director at Opthea - View - Opthea org chart
Create your alert
to follow the career of Daniel Spiegelman.
Education
In 1980, Daniel Spiegelman completed a Bachelor of Arts in Economics at Stanford University.
They have also studied at Stanford University :
Find more alumni from Stanford University
More about Daniel Spiegelman
Selected links
Do you need to know more about Daniel Spiegelman? More results.
Participate
Social media
- Daniel Spiegelman on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Daniel Spiegelman
The colleagues of Daniel Spiegelman
Company Colleagues
- At Maze Therapeutics, Daniel Spiegelman has 17 colleagues including Jason Coloma (CEO & Director), Catherine Sohn (Director)…
- At Myriad Genetics, Daniel Spiegelman has 42 colleagues including Paul Diaz (CEO & Director), Heiner Dreismann (Director)…
- At Opthea, Daniel Spiegelman has 20 colleagues including Frederic Guerard (CEO), Quinton Oswald (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Daniel Spiegelman has 19,336 colleagues in 1,861 companies located in 69 countries. 8,405 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Daniel Spiegelman.
Get in Touch
Sorry, but Daniel Spiegelman cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Daniel Spiegelman listed below. Here are a few tips for establishing great contacts.
and ask for Daniel Spiegelman.
